19G FNB Needle Vs 22G FNB Needle for EUS-Guided Liver Biopsy

Last updated: October 13, 2024
Sponsor: Duzce University
Overall Status: Active - Recruiting

Phase

4

Condition

N/A

Treatment

19-gauge

22-gauge

Clinical Study ID

NCT06643520
EUS-LB
  • Ages 18-80
  • All Genders

Study Summary

EUS-guided liver biopsy (EUS-LB) is increasingly used to diagnose patients with liver disease, especially in anxious patients who need sedation. There is an ongoing debate about the optimal needle size for EUS-LB. Some clinicians prefer a thinner 22-gauge biopsy needle because they presume it to be safer, and some studies show that their performance is the same as a thicker 19-gauge needle. However, some other studies show that the adequacy and diagnostic accuracy of a 19-gauge needle is better, and the rates of adverse events are the same. In this study, we aimed to compare the adequacy and diagnostic accuracy of samples obtained by the same endoscopist from the same liver lobe during the same session.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All patients with unexplained elevation of liver enzymes and suspected hepaticparanchymal disease

Exclusion

Exclusion Criteria:

  • Patients who had malignancy

  • Patients who have decompensated cirrhosis

  • Presence of ascites

  • Patients with coagulopathy (platelets < 50.000 μ/ mL and INR > 1.5)

  • The use of anticoagulant agents

  • Pregnancy

  • Unable to provide written informed consent

Study Design

Total Participants: 82
Treatment Group(s): 2
Primary Treatment: 19-gauge
Phase: 4
Study Start date:
July 01, 2024
Estimated Completion Date:
April 01, 2025

Connect with a study center

  • Duzce University

    Duzce, 81620
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.